Search research articles
Contact Us
Filters
Showing results (11-20 of 202) with videos related to
Page
of 21
Sort By:
Sleep
|
November 19, 2014
The patient's or society's: whose quality of life is it anyway?
Logan Trenaman, Najib Ayas, Nick Bansback
Current Gastroenterology Reports
|
September 19, 2014
Impact of inflammatory bowel disease on disability
Katharina Büsch, Amnon Sonnenberg, Nick Bansback
Current Rheumatology Reports
|
April 24, 2015
How important is mode of administration in treatments for rheumatic diseases and related conditions?
Nick Bansback, Logan Trenaman, Mark Harrison
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
April 30, 2024
Can prediction models for hospital readmission be improved by incorporating patient-reported outcome measures? A systematic review and narrative synthesis
Maggie Yu, Mark Harrison, Nick Bansback
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
A pharmacoeconomic review of adalimumab in the treatment of rheumatoid arthritis
Nick Bansback, Alan Brennan, Aslam H Anis
Annals of Internal Medicine
|
March 3, 2010
Cost-effectiveness of biologics in early rheumatoid arthritis
Axel Finckh, Nick Bansback, Matthew H Liang
Health Economics
|
May 14, 2016
Preferences for 'New' Treatments Diminish in the Face of Ambiguity
Mark Harrison, Carlo A Marra, Nick Bansback
Social Science & Medicine (1982)
|
December 15, 2010
Measuring and valuing productivity loss due to poor health: A critical review
Wei Zhang, Nick Bansback, Aslam H Anis
The Journal of Rheumatology
|
July 13, 2006
A prognostic model for functional outcome in early rheumatoid arthritis
Nick Bansback, Adam Young, Alan Brennan, et al.
Rheumatology (Oxford, England)
|
August 24, 2011
The Sheffield rheumatoid arthritis health economic model
Jonathan Tosh, Alan Brennan, Allan Wailoo, et al.
Page
of 21
Search research articles
Search
Showing results (11-20 of 202) with videos related to
Sort By:
Page
of 21
Sleep
|
November 19, 2014
The patient's or society's: whose quality of life is it anyway?
Logan Trenaman, Najib Ayas, Nick Bansback
Current Gastroenterology Reports
|
September 19, 2014
Impact of inflammatory bowel disease on disability
Katharina Büsch, Amnon Sonnenberg, Nick Bansback
Current Rheumatology Reports
|
April 24, 2015
How important is mode of administration in treatments for rheumatic diseases and related conditions?
Nick Bansback, Logan Trenaman, Mark Harrison
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
April 30, 2024
Can prediction models for hospital readmission be improved by incorporating patient-reported outcome measures? A systematic review and narrative synthesis
Maggie Yu, Mark Harrison, Nick Bansback
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 8, 2009
A pharmacoeconomic review of adalimumab in the treatment of rheumatoid arthritis
Nick Bansback, Alan Brennan, Aslam H Anis
Annals of Internal Medicine
|
March 3, 2010
Cost-effectiveness of biologics in early rheumatoid arthritis
Axel Finckh, Nick Bansback, Matthew H Liang
Health Economics
|
May 14, 2016
Preferences for 'New' Treatments Diminish in the Face of Ambiguity
Mark Harrison, Carlo A Marra, Nick Bansback
Social Science & Medicine (1982)
|
December 15, 2010
Measuring and valuing productivity loss due to poor health: A critical review
Wei Zhang, Nick Bansback, Aslam H Anis
The Journal of Rheumatology
|
July 13, 2006
A prognostic model for functional outcome in early rheumatoid arthritis
Nick Bansback, Adam Young, Alan Brennan, et al.
Rheumatology (Oxford, England)
|
August 24, 2011
The Sheffield rheumatoid arthritis health economic model
Jonathan Tosh, Alan Brennan, Allan Wailoo, et al.
Page
of 21